These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 19825472)
1. Type a botulinum toxin-induced antibody production: a murine model of antibody response. Sutphin DD; Chun J; Hill W; Kirkpatrick S; Mountain D; Packan W; Muenchen R Aesthet Surg J; 2009; 29(5):414-8. PubMed ID: 19825472 [TBL] [Abstract][Full Text] [Related]
2. Commentary. Kane MA Aesthet Surg J; 2009; 29(5):418-20. PubMed ID: 19825473 [No Abstract] [Full Text] [Related]
3. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study. Magid M; Reichenberg JS; Poth PE; Robertson HT; LaViolette AK; Kruger TH; Wollmer MA J Clin Psychiatry; 2014 Aug; 75(8):837-44. PubMed ID: 24910934 [TBL] [Abstract][Full Text] [Related]
4. A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis. Elkind AH; O'Carroll P; Blumenfeld A; DeGryse R; Dimitrova R; J Pain; 2006 Oct; 7(10):688-96. PubMed ID: 17018329 [TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production. Ho MC; Hsu WC; Hsieh YT JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079 [TBL] [Abstract][Full Text] [Related]
6. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Topazian M; Camilleri M; De La Mora-Levy J; Enders FB; Foxx-Orenstein AE; Levy MJ; Nehra V; Talley NJ Obes Surg; 2008 Apr; 18(4):401-7. PubMed ID: 18286347 [TBL] [Abstract][Full Text] [Related]
7. [Botulinum toxin type A decreases the concentration of acetylcholinesterase in nasal glands of guinea pig]. Chen F; Wang J; Liu S; Mi W; Wang Y Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Apr; 19(8):370-2. PubMed ID: 16075995 [TBL] [Abstract][Full Text] [Related]
8. Sebum Production Alteration after Botulinum Toxin Type A Injections for the Treatment of Forehead Rhytides: A Prospective Randomized Double-Blind Dose-Comparative Clinical Investigation. Min P; Xi W; Grassetti L; Trisliana Perdanasari A; Torresetti M; Feng S; Su W; Pu Z; Zhang Y; Han S; Zhang YX; Di Benedetto G; Lazzeri D Aesthet Surg J; 2015 Jul; 35(5):600-10. PubMed ID: 25825422 [TBL] [Abstract][Full Text] [Related]
9. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications. Dressler D; Wohlfahrt K; Meyer-Rogge E; Wiest L; Bigalke H Dermatol Surg; 2010 Dec; 36 Suppl 4():2182-7. PubMed ID: 21134050 [TBL] [Abstract][Full Text] [Related]
10. Antibodies after botulinum toxin A injection into musculus detrusor vesicae: incidence and clinical relevance. Hegele A; Frohme C; Varga Z; Olbert P; Kranz J; Hofmann R Urol Int; 2011; 87(4):439-44. PubMed ID: 22004911 [TBL] [Abstract][Full Text] [Related]
11. Topical diltiazem cream versus botulinum toxin a for the treatment of chronic anal fissure: a double-blind randomized clinical trial. Samim M; Twigt B; Stoker L; Pronk A Ann Surg; 2012 Jan; 255(1):18-22. PubMed ID: 21685792 [TBL] [Abstract][Full Text] [Related]
12. The effect of total cumulative dose, number of treatment cycles, interval between injections, and length of treatment on the frequency of occurrence of antibodies to botulinum toxin type A in the treatment of muscle spasticity. Bakheit AM; Liptrot A; Newton R; Pickett AM Int J Rehabil Res; 2012 Mar; 35(1):36-9. PubMed ID: 22108625 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and complications of dose increments of botulinum toxin-A in the treatment of horizontal comitant strabismus. Sener EC; Sanaç AS Eye (Lond); 2000 Dec; 14(Pt 6):873-8. PubMed ID: 11584846 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A injection for refractory interstitial cystitis: A randomized comparative study and predictors of treatment response. Akiyama Y; Nomiya A; Niimi A; Yamada Y; Fujimura T; Nakagawa T; Fukuhara H; Kume H; Igawa Y; Homma Y Int J Urol; 2015 Sep; 22(9):835-41. PubMed ID: 26041274 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy and side-effects of the botulinum toxin A treatment in patients with focal dystonia]. Likhachev SA; Rushkevich IuN; Chernukha TN; Veevnik EV Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):27-31. PubMed ID: 19365387 [TBL] [Abstract][Full Text] [Related]
17. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections. Sankhla C; Jankovic J; Duane D Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341 [TBL] [Abstract][Full Text] [Related]
18. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial. Hexsel D; Brum C; do Prado DZ; Soirefmann M; Rotta FT; Dal'Forno T; Rodrigues TC J Am Acad Dermatol; 2012 Aug; 67(2):226-32. PubMed ID: 22041253 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin treatment in patients up to 3 years of age who have esotropic Duane retraction syndrome. Maya JF; de Liaño RG; Catalán MR; Rayward O Strabismus; 2013 Mar; 21(1):4-7. PubMed ID: 23477770 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of botulinum toxin type A 100 Units versus 200 units for treatment of refractory idiopathic overactive bladder. Abdelwahab O; Sherif H; Soliman T; Elbarky I; Eshazly A Int Braz J Urol; 2015; 41(6):1132-40. PubMed ID: 26742971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]